Cytokine StormIn some patients there is something called cytokine storm cytokine release syndrome it's ikely to be happening now we still don't understand how this comes about but the prediction is perhaps not controlling the virus early or there's a dysregulated immune response that is taking place so what happens is then there is an amplification of the immune response to this virus so immune cells are getting activated they are producing these factors and cytokines interleukin the interference and they're activating each other as a way of communicating and it gets amplified so what happens in cytokine release syndrome is that we are making lots of anti cytokines rapidly within a short period of time and this can have systemic consequences it can actually affect all parts of our system you can affect different organs including your lungs your heart so it's believed I think the cytokine storm that we are seeing in these patients is a key part of the severity of the disease.
Immune responses during COVID-19 infectionThis review will discuss innate and cognate immune responses underlying protective or deleterious immune reactions against these pathogenic coronaviruses.
Cléa Melenotte, et al., Oncoimmunology. 2020; 9(1): 1807836. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480812/ |
In this 12-minute video (banned for public viewing but still available on BeforeItsNews) Prof. Dolores Cahill explains the results of a 2012 study which looks at the effects of vaccines for SARS-CoV-1. The study entitled Immunization with SARS Coronavirus Vaccine Leads to Pulmonary Immunopathology on Challenge with the SARS Virus, showed that coronavirus vaccines can lead to antibody dependent response (also known by several terms such as cytokine storm, immuno-priming, immuno-super priming or pathogenic priming) and must be used with caution on humans. Prof. Cahill says that this is the reason why no coronavirus vaccines has been licensed for human use.
References: [HTML] Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virusCT Tseng, E Sbrana, N Iwata-Yoshikawa, PC Newman… - PloS one, 2012 - journals.plos.org … a deliberate release of the SARS coronavirus, vaccine development was initiated. Evaluations … However, challenge of mice given any of the vaccines led to occurrence of Th2-type … buffered formalin for histological examination and immunohistochemistry (IHC), as described … |